banner
bibliotecahuvh.bsky.social
@bibliotecahuvh.bsky.social
Biblioteca del Vall d’Hebron Barcelona Hospital Campus
Pinned
Cerqueu els articles dels autors @vallhebroncampus.bsky.social
per la seva especialitat indicant: #hvhebron + etiqueta (per exemple #hvhebron #onco )
I afegiu "Text complet" per llegir els que estan en accés obert (#hvhebron #onco [Text complet])
Etiquetes creades 👇
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial) www.sciencedirect.com/science/arti... #hvhebron #malinf [Text complet]
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)
We evaluated the efficacy, safety and impact on viral reservoir of rapid bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) initiation duri…
www.sciencedirect.com
December 4, 2025 at 1:19 PM
Migraine management during pregnancy, breastfeeding and in women planning pregnancy journals.sagepub.com/doi/10.1177/... #hvhebron #neuro [Text complet]
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
December 4, 2025 at 1:17 PM
The SIDECAR 2.0 (S-ICD registry in European paediatric and young adult patients with congenital heart defects 2.0): an analysis of European S-ICD clinical practice and its evolution in paediatric patients academic.oup.com/europace/art... #hvhebron #cardioped [Text complet]
The SIDECAR 2.0 (S-ICD registry in European paediatric and young adult patients with congenital heart defects 2.0): an analysis of European S-ICD clinical practice and its evolution in paediatric pati...
AbstractAims. Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are effective in patients who require protection from sudden cardiac death whil
academic.oup.com
December 4, 2025 at 1:16 PM
Characterisation of new HIV diagnoses achieved in emergency departments using an opt-in strategy, Catalonia, Spain, July 2021 to March 2024 www.eurosurveillance.org/content/10.2... #hvhebron #micro #malinf [Text complet]
Characterisation of new HIV diagnoses achieved in emergency departments using an opt-in strategy, Catalonia, Spain, July 2021 to March 2024
BACKGROUND HIV screening strategies in alternative settings, such as emergency departments (EDs), aim to increase diagnosis of occult infections and achieve 95–95–95 targets for 2030. AIM To assess the effectiveness of an opt-in HIV screening strategy in EDs based on six clinical scenarios from a 2020 Spanish consensus document, while examining patient characteristics and linkage to-care. METHODS This descriptive, multicentre, retrospective study analysed epidemiological, clinical, and linkage-to-care data of individuals aged ≥ 18 years newly diagnosed with HIV between July 2021 and March 2024 in 17 EDs covering 73% of the population in Catalonia, Spain. RESULTS From 23,105 HIV serologies performed, there were 172 new diagnoses (positivity rate: 0.7%). Of these, 88.4% (152/172) were assigned male at birth, had a median age of 39 years (IQR: 30–50), and 47.9% (81/169) were Spanish. Sexual transmission was reported in 75.6% (130/172) of cases, with 55.5% (81/146) heterosexual. Fiebig stage data, available in 78.5% (135/172) of cases, showed 57.8% (78/135) had acute infection. Advanced HIV was found in 24.2% (30/124). Diagnoses related to the six clinical scenarios accounted for 54.6% (94/172) of cases. For all new diagnoses, 82.0% (137/167) were linked to specialised healthcare and started antiretroviral treatment within 9 days (IQR: 4–17), with no significant differences regarding urban/rural hospital coverage areas. CONCLUSION An opt-in HIV screening strategy in the ED is feasible and effective, especially in detecting highly transmissible patients with acute infection. However, one in five newly diagnosed individuals remained untreated, highlighting the need for improved linkage to care.
www.eurosurveillance.org
December 4, 2025 at 1:01 PM
Feasibility of an AI-assisted transcranial duplex sonography protocol for early detection of intracerebral haemorrhage: the HYPER-AI-SCAN single-centre prospective study bmjopen.bmj.com/content/15/1... #hvhebron #neuro [Text complet]
Feasibility of an AI-assisted transcranial duplex sonography protocol for early detection of intracerebral haemorrhage: the HYPER-AI-SCAN single-centre prospective study
Introduction Intracerebral haemorrhage (ICH) is associated with high early mortality and morbidity. Early clinical deterioration is common and influenced by haematoma expansion, which can occur within...
bmjopen.bmj.com
December 4, 2025 at 12:59 PM
Unveiling the enterovirus diversity in Barcelona, Spain (2020-2024) through wastewater and clinical surveillance www.tandfonline.com/doi/full/10.... #hvhebron #micro [Text complet]
Unveiling the enterovirus diversity in Barcelona, Spain (2020–2024) through wastewater and clinical surveillance
Enterovirus (EV) infections are common and often mild or asymptomatic but can occasionally cause serious illness in children. Routine clinical surveillance typically underestimates the full spectru...
www.tandfonline.com
December 4, 2025 at 12:53 PM
Histology-informed microstructural diffusion simulations for MRI cancer characterisation-the Histo-μSim framework www.nature.com/articles/s42... #hvhebron #onco [Text complet]
Histology-informed microstructural diffusion simulations for MRI cancer characterisation—the Histo-μSim framework - Communications Biology
A histology-informed, diffusion Magnetic Resonance Imaging simulation framework improves the non-invasive assessment of cancer biology in solid tumours in vivo
www.nature.com
December 4, 2025 at 12:52 PM
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia ashpublications.org/bloodadvance... #hvhebron #onco [Text complet]
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia
Key PointsCDKN2A and BCL2 SNPs are newly linked to CLL risk, with CDKN2A rs3731204 showing the strongest association (P = 1.57 × 10−12).These variants are
ashpublications.org
December 4, 2025 at 12:50 PM
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310 www.sciencedirect.com/science/arti...
December 4, 2025 at 12:34 PM
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial www.sciencedirect.com/science/arti... #hvhebron #malinf [Text complet]
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
To date, clinical trials have been underpowered to assess which antiretrovirals perform best in people with advanced HIV disease. We aimed to investig…
www.sciencedirect.com
December 4, 2025 at 12:33 PM
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial
Everolimus or streptozotocin plus 5-fluorouracil (STZ/5-FU) are approved treatments for patients with pancreatic neuroendocrine tumors (panNETs). The …
www.sciencedirect.com
December 4, 2025 at 12:32 PM
Adapting the implementation of clinical practice guidelines for the screening of infectious diseases and female genital mutilation/cutting in migrants in Spain www.sciencedirect.com/science/arti... #hvhebron #malinf [Text complet]
Adapting the implementation of clinical practice guidelines for the screening of infectious diseases and female genital mutilation/cutting in migrants in Spain
We aimed to adapt the implementation of infectious diseases(IDs) and female genital mutilation/cutting(FGM/C) screening, and vaccination recommendatio…
www.sciencedirect.com
December 4, 2025 at 12:31 PM
El papel del ejercicio físico en la salud cardiovascular de la mujer. Documento de posicionamiento de SEC-Asociación de Cardiología Preventiva/SEC-GT Ejercicio Físico y Salud Cardiovascular www.sciencedirect.com/science/arti... #hvhebron #obstetriciahvh
El papel del ejercicio físico en la salud cardiovascular de la mujer. Documento de posicionamiento de SEC-Asociación de Cardiología Preventiva/SEC-GT Ejercicio Físico y Salud Cardiovascular
La enfermedad cardiovascular sigue siendo la primera causa de muerte en la mujer a nivel mundial. La cardiopatía isquémica y el accidente cerebrovascu…
www.sciencedirect.com
December 4, 2025 at 12:29 PM
Regional inequalities in heart failure hospitalisation and in-hospital mortality in Spain (2016–2022): a nationwide, observational study www.sciencedirect.com/science/arti... #hvhebron #cardio [Text complet]
Regional inequalities in heart failure hospitalisation and in-hospital mortality in Spain (2016–2022): a nationwide, observational study
Heart failure remains one of the leading causes of hospital admissions and mortality worldwide, with substantial regional disparities in clinical outc…
www.sciencedirect.com
December 4, 2025 at 12:27 PM
Giants in Infectious Diseases: Prof. Jose M. Miro's translational research in infective endocarditis www.sciencedirect.com/science/arti... #hvhebron #hepato
Giants in Infectious Diseases: Prof. Jose M. Miro's translational research in infective endocarditis
www.sciencedirect.com
December 4, 2025 at 12:23 PM
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial
The use of immune checkpoint inhibitors (ICIs) in metastatic colorectal cancer (mCRC) remains limited to tumors harboring microsatellite instability (…
www.sciencedirect.com
December 4, 2025 at 12:20 PM
Diagnóstico diferencial de edema periorbitario en drepanocitosis www.sciencedirect.com/science/arti... #hvhebron #hemat [Text complet]
Diagnóstico diferencial de edema periorbitario en drepanocitosis
www.sciencedirect.com
December 4, 2025 at 12:18 PM
Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors aacrjournals.org/clincancerre... #hvhebron #onco [Text complet]
Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors
AbstractPurpose:. To evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of ficerafusp alfa (BCA101), a first-in-class bifunctional protein targeting EGFR and TGF-β, as monotherapy a...
aacrjournals.org
December 4, 2025 at 12:06 PM
Quality of Life and Cognitive Function in Pediatric Patients Undergoing Surgery for Heart Diseases: A Rapid Systematic Review and Meta-Analysis www.imrpress.com/journal/hsf/... #hvhebron #infermeriahvh [Text complet]
Quality of Life and Cognitive Function in Pediatric Patients Undergoing Surgery for Heart Diseases: A Rapid Systematic Review and Meta-Analysis
Background: Scientific attention is increasingly being drawn to the emotional impact and neurodevelopmental difficulties experienced by children and adolescents with heart disease....
www.imrpress.com
December 4, 2025 at 12:02 PM
Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients academic.oup.com/bjd/advance-... #hvhebron #der
Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients
This study assessed skin cancer risk in 1,055 solid organ transplant recipients over 10 years at Vall d’Hebron University Hospital. MTORI-based regimens, e
academic.oup.com
December 3, 2025 at 4:20 PM
Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysi www.nature.com/articles/s41... #hvhebron #onco
Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis - Bone Marrow Transplantation
Bone Marrow Transplantation - Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis
www.nature.com
December 3, 2025 at 4:19 PM
New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study onlinelibrary.wiley.com/doi/10.1111/... #hvhebron #neuro [Text complet]
New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study
Background and Purpose Guidelines recommend stent retrievers (SRs) for treating large vessel occlusion (LVO) stroke. We assessed noninferiority of the iNtercept (iVascular) SR with a self-expanding ...
onlinelibrary.wiley.com
December 3, 2025 at 4:19 PM
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801 link.springer.com/article/10.1... #hvhebron #onco [Text complet]
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801 - Clinical and Translational Oncology
Purpose Anti-PD-1-based immunotherapy and targeted therapies (TT) are the current standard of care for patients with advanced melanoma. However, some patients die in less than a year from diagnosis an...
link.springer.com
December 3, 2025 at 4:17 PM